Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy.
about
Platensimycin activity against mycobacterial beta-ketoacyl-ACP synthasesStrategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptidesMycobacterium tuberculosis proteins involved in mycolic acid synthesis and transport localize dynamically to the old growing pole and septumX-Ray Crystal Structure of Mycobacterium tuberculosis β-Ketoacyl Acyl Carrier Protein Synthase II (mtKasB)Crystal Structures of Mycobacterium tuberculosis KasA Show Mode of Action within Cell Wall Biosynthesis and its Inhibition by ThiolactomycinPathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosisMycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector moleculeThe virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosisInvestigating the function of the putative mycolic acid methyltransferase UmaA: divergence between the Mycobacterium smegmatis and Mycobacterium tuberculosis proteinsTrans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulenceThe missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosisA unique Mycobacterium ESX-1 protein co-secretes with CFP-10/ESAT-6 and is necessary for inhibiting phagosome maturationDeletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent miceThe condensing activities of the Mycobacterium tuberculosis type II fatty acid synthase are differentially regulated by phosphorylationPhosphorylation of KasB regulates virulence and acid-fastness in Mycobacterium tuberculosisRole for lysosomal enzyme beta-hexosaminidase in the control of mycobacteria infection.The crucial role of trehalose and structurally related oligosaccharides in the biosynthesis and transfer of mycolic acids in Corynebacterineae.FbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis.Loss of a mycobacterial gene encoding a reductase leads to an altered cell wall containing beta-oxo-mycolic acid analogs and accumulation of ketones.Polar localization of virulence-related Esx-1 secretion in mycobacteria.Identification of Mycobacterium avium genes associated with resistance to host antimicrobial peptides.New small-molecule synthetic antimycobacterials.A Mycobacterium marinum TesA mutant defective for major cell wall-associated lipids is highly attenuated in Dictyostelium discoideum and zebrafish embryos.Role of the WASP family proteins for Mycobacterium marinum actin tail formation.The Mycobacterium tuberculosis FAS-II dehydratases and methyltransferases define the specificity of the mycolic acid elongation complexes.Involvement of two latex-clearing proteins during rubber degradation and insights into the subsequent degradation pathway revealed by the genome sequence of Gordonia polyisoprenivorans strain VH2Diversion of phagosome trafficking by pathogenic Rhodococcus equi depends on mycolic acid chain length.Insights into early mycobacterial pathogenesis from the zebrafish.Regulation of Mycobacterium tuberculosis cell envelope composition and virulence by intramembrane proteolysisSimple and rapid characterization of mycolic acids from Dietzia strains by using MALDI spiral-TOFMS with ultra high mass-resolving power.Essential Role of the ESX-5 Secretion System in Outer Membrane Permeability of Pathogenic MycobacteriaMycobacterium smegmatis RoxY is a repressor of oxyS and contributes to resistance to oxidative stress and bactericidal ubiquitin-derived peptidesCrystal Structure of Fad35R from Mycobacterium tuberculosis H37Rv in the Apo-State.PPE38 modulates the innate immune response and is required for Mycobacterium marinum virulence.CpsA, a LytR-CpsA-Psr Family Protein in Mycobacterium marinum, Is Required for Cell Wall Integrity and VirulenceMolecular basis for the inhibition of β-hydroxyacyl-ACP dehydratase HadAB complex from Mycobacterium tuberculosis by flavonoid inhibitors.Both phthiocerol dimycocerosates and phenolic glycolipids are required for virulence of Mycobacterium marinum.Persistent bacterial infections: the interface of the pathogen and the host immune system.Characterization of Mycolic Acids in Total Fatty Acid Methyl Ester Fractions from Mycobacterium Species by High Resolution MALDI-TOFMS.A Duplicated ESAT-6 Region of ESX-5 Is Involved in Protein Export and Virulence of Mycobacteria.
P2860
Q21562402-EA245A0D-8673-4D76-B082-422521C7F43CQ26861137-637D6183-8938-4F7F-B31A-FB5C71C5436FQ27333131-F45E9146-1255-4072-B639-B4A1E4E4D9B6Q27640802-021525A3-2BE2-4246-9F30-438A871D7A10Q27656454-70E5C2DC-0809-493E-A0B3-201E7E2CAA6AQ28302775-E4D80EC4-70E7-40E3-8EFB-BEC17598EF5DQ28486490-E06FE5D2-8494-46A7-BB88-E48DE5906A5FQ28486587-CA659538-DCAA-4350-A481-75FBAC67F41AQ28486588-A21747D6-93A1-47FB-BAFB-41EB0F6190DDQ28486653-54327F69-5EB2-4995-BDAB-3E061A1200A1Q28486719-AA9F4EA1-63FA-474F-B7BF-3CD001818B83Q28486984-CC4E476F-4EA2-4004-9103-9E70ED806FEAQ28487228-58E038F9-5612-4751-9578-EE424AB24C50Q28487302-15FCD13A-0289-42DE-8596-FC4B7A5D64AEQ28538596-419E592D-865A-46C9-8890-26841576FB4BQ30481087-2F3AFEA8-7AAA-4685-B30F-D4E9804EF2B6Q33215308-999F5539-F6AB-48F0-BB67-4DFA57A18370Q33223435-B2FC49DB-596B-416E-91C7-1E5EB59C5D18Q33370732-D337504D-B28C-49CD-B0A3-8BD1975146F1Q33404091-6CF4E08A-CB82-4704-9B6A-91B4A7475324Q33781238-DFEDFE5B-690C-441B-B747-92E9ABE384DCQ33836780-89802E4C-E4ED-482F-8734-2D25C69B12B3Q33837348-689E970B-BCE0-4B2A-BD6C-FAAF08BEFC75Q34055490-B5748943-CDD3-4504-8A07-F54F4F3F4722Q34117721-60CB9C91-0B18-4865-9250-EB3D6081B972Q34156855-89E94AC0-60B0-4451-A77E-C50FC26BB380Q34306954-EA982FBE-1D98-4110-A51F-8CAF27E5A470Q34767512-EEAE969F-821E-4703-A907-633D57819BE3Q34770334-A30CA5E9-4E4B-4D57-812A-A9C8C20BDBF7Q34975189-05A6DDC0-8E9B-4400-A739-504C0A08B748Q35566537-BAF753F7-B235-4ADA-9A00-660328742091Q35598609-A4F3D352-DD45-4A56-A51E-E8677CE9CA3DQ35621446-C938AEF6-B293-42A1-AF71-BB81BE7D1872Q35665434-AA6CAC45-89A8-478B-803E-B91502648371Q35745625-EFADC58E-94E4-47A7-A40B-093EDE99D12BQ35816062-FE9F3DA3-1E6B-4B26-B39C-3B7DBD6F5C11Q35867580-A3EEB2B9-795B-4408-98C1-72454122A7D0Q35889600-172A885D-DC6A-45B7-9A90-1736CE3BBC36Q35906843-0B409804-0806-438C-B217-B3A142FEDD7FQ36137948-19177C6D-1311-443A-84AA-DF1103132ABD
P2860
Requirement for kasB in Mycobacterium mycolic acid biosynthesis, cell wall impermeability and intracellular survival: implications for therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Requirement for kasB in Mycoba ...... val: implications for therapy.
@ast
Requirement for kasB in Mycoba ...... val: implications for therapy.
@en
type
label
Requirement for kasB in Mycoba ...... val: implications for therapy.
@ast
Requirement for kasB in Mycoba ...... val: implications for therapy.
@en
prefLabel
Requirement for kasB in Mycoba ...... val: implications for therapy.
@ast
Requirement for kasB in Mycoba ...... val: implications for therapy.
@en
P2093
P1476
Requirement for kasB in Mycoba ...... val: implications for therapy.
@en
P2093
Andy Woodruff
Elise H Lawson
Eric J Brown
Francoise Laval
J Hiroshi Morisaki
Jeffery S Cox
Lian-Yong Gao
Mamadou Daffe
Richard K Groger
P304
P356
10.1046/J.1365-2958.2003.03667.X
P407
P577
2003-09-01T00:00:00Z